Where Will Nu Holdings Stock Be in 2030?
Despite fast growth, high profitability and an extraordinary runway ahead,…
Sell
44
NTR Quote, Financials, Valuation and Earnings
Last price:
$49.57
Seasonality move
:
2.67%
Day range:
$49.05 - $50.07
52-week range:
$43.70 - $60.87
Dividend yield:
4.37%
P/E ratio:
36.18x
P/S ratio:
0.94x
P/B ratio:
0.99x
Volume:
1.7M
Avg. volume:
2.4M
1-year change:
-9.66%
Market cap:
$24.2B
Revenue:
$26B
EPS (TTM):
$1.37
Analysts' Opinion
-
Consensus RatingNutrien has received a consensus rating of Buy. The company's average rating is a Buy based on 10 Buy ratings, 8 Hold ratings, and 1 Sell rating.
-
Price Target UpsideAccording to analysts' consensus price target of $60.51, Nutrien has an estimated upside of 22.09% from its current price of $49.56.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $50.00 representing -0.89% downside risk from its current price of $49.56.
Fair Value
-
According to the consensus of 19 analysts, Nutrien has 22.09% upside to fair value with a price target of $60.51 per share.
NTR vs. S&P 500
-
Over the past 5 trading days, Nutrien has overperformed the S&P 500 by 1% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Nutrien does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Nutrien revenues have been falling on a year-over-year basis for 8 quarters in a row. In the most recent quarter Nutrien reported revenues of $5.1B.
Earnings Growth
-
Nutrien earnings have been falling on a year-over-year basis for 8 quarters in a row. In the most recent quarter Nutrien reported earnings per share of $0.23.
Enterprise value:
34.9B
EV / Invested capital:
--
Price / LTM sales:
0.94x
EV / EBIT:
18.62x
EV / Revenue:
1.34x
PEG ratio (5yr expected):
--
EV / Free cash flow:
25.26x
Price / Operating cash flow:
17.74x
Enterprise value / EBITDA:
8.28x
Gross Profit (TTM):
$7.5B
Return On Assets:
1.28%
Net Income Margin (TTM):
2.6%
Return On Equity:
2.7%
Return On Invested Capital:
1.82%
Operating Margin:
9.27%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $37.9B | $29.1B | $26B | $5.7B | $5.1B | |
| Gross Profit | $15.4B | $8.5B | $7.5B | $1.8B | $1.6B | |
| Operating Income | $10.2B | $3.9B | $2.9B | $477M | $471M | |
| EBITDA | $12.8B | $4.9B | $4.2B | $829M | $1B | |
| Diluted EPS | $14.09 | $2.53 | $1.37 | $0.35 | $0.23 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $11.5B | $13.8B | $16.3B | $14.2B | $13.8B | |
| Total Assets | $47.2B | $50B | $54.6B | $52.7B | $51.8B | |
| Current Liabilities | $8.5B | $12.4B | $14.3B | $12.1B | $12B | |
| Total Liabilities | $24.8B | $26.3B | $28.7B | $27.5B | $27.4B | |
| Total Equity | $22.4B | $23.7B | $25.9B | $25.2B | $24.4B | |
| Total Debt | $10.2B | $9.6B | $10.7B | $11.2B | $11.5B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $8.1B | $5.1B | $3.5B | $4.2B | $3.1B | |
| Cash From Investing | -$2.9B | -$3B | -$2.1B | -$733M | -$519M | |
| Cash From Financing | -$4.7B | -$2.1B | -$1.5B | -$3B | -$2.2B | |
| Free Cash Flow | $5.6B | $2.5B | $1.4B | $3.4B | $2.4B | |
NTR
Sector
Market Cap
$24.2B
$18.4M
Price % of 52-Week High
81.42%
60.93%
Dividend Yield
4.37%
0%
Shareholder Yield
7.7%
1.21%
1-Year Price Total Return
-9.66%
-12.67%
Beta (5-Year)
0.779
0.927
Dividend yield:
4.37%
Annualized payout:
$2.16
Payout ratio:
157.27%
Growth streak:
7 years
Technicals
8-day SMA
Sell
Level
$50.74
200-day SMA
Buy
Level
$49.10
Bollinger Bands (100)
Buy
Level
46.71 - 52.09
Chaikin Money Flow
Sell
Level
-17.5M
20-day SMA
Sell
Level
$50.91
Relative Strength Index (RSI14)
Sell
Level
41.29
ADX Line
Sell
Level
15.25
Williams %R
Buy
Level
-85.7471
50-day SMA
Sell
Level
$51.53
MACD (12, 26)
Sell
Level
-0.29
25-day Aroon Oscillator
Sell
Level
-16
On Balance Volume
Sell
Level
-28.3M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (1.4418)
Buy
CA Score
(Annual)
Level (-0.2289)
Buy
Beneish M-Score
(Annual)
Level (-2.772)
Buy
Momentum Score
Level (6)
Buy
Ohlson Score
Level (-0.5627)
Buy
Piotroski F Score
(Annual)
Level (4)
Buy
Quality Ratio Score
Level (3)
Buy
Fundamental Score
Level (9)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Created in 2018 as a result of the merger between PotashCorp and Agrium, Nutrien is the world’s largest fertilizer producer by capacity. Nutrien produces the three main crop nutrients - nitrogen, potash, and phosphate - although its main focus is potash, where it is the global leader in installed capacity with a roughly 20% market share. The company is also the largest agricultural retailer in North America and Australia, selling fertilizers, crop chemicals, seeds, and services directly to farm customers through its brick-and-mortar stores and online platforms.
Stock Forecast FAQ
In the current month, NTR has received 10 Buy ratings 8 Hold ratings, and 1 Sell ratings. The NTR average analyst price target in the past 3 months is $60.51.
-
Where Will Nutrien Stock Be In 1 Year?
According to analysts, the consensus estimate is that Nutrien share price will rise to $60.51 per share over the next 12 months.
-
What Do Analysts Say About Nutrien?
Analysts are divided on their view about Nutrien share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Nutrien is a Sell and believe this share price will drop from its current level to $50.00.
-
What Is Nutrien's Price Target?
The price target for Nutrien over the next 1-year time period is forecast to be $60.51 according to 19 Wall Street analysts, 10 of them rate the stock a Buy, 1 rates the stock a Sell, and 8 analysts rate the stock a Hold.
-
Is NTR A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Nutrien is a Buy. 10 of 19 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of NTR?
You can purchase shares of Nutrien via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Nutrien shares.
-
What Is The Nutrien Share Price Today?
Nutrien was last trading at $49.57 per share. This represents the most recent stock quote for Nutrien. Yesterday, Nutrien closed at $49.56 per share.
-
How To Buy Nutrien Stock Online?
In order to purchase Nutrien stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is it Too Late to Buy United Airlines Stock?
United Airlines (NASDAQ:UAL) has thoroughly outpaced the broader stock market…
3 Smartest Dividend Stocks to Buy Now
When the market entered a correction in February and March,…
Stock Ideas
Buy
56
Is AAPL Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 37x
Sell
46
Is MSFT Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 32x
Sell
42
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 37x
Alerts
Buy
100
DLICY alert for Apr 2
Dai-ichi Life Holdings [DLICY] is up 100.91% over the past day.
Buy
78
GATE alert for Apr 2
Marblegate Acquisition [GATE] is up 86.64% over the past day.
Sell
15
PCVX alert for Apr 2
Vaxcyte [PCVX] is down 14.62% over the past day.
